Clinical Trial

1
2
3
4

Trial Location: Guntur Medical College and Government General Hospital
Duration: 27th November 1987 to 15th May 1988
No of Participating Patients: 46
Duration: 27th November 1987 to 15th May 1988
No of Participating Patients: 46
Summary of the Report
Kamalahar showed significantly good results in the treatment of Infective Hepatitis, Anti-tubercular drugs induced jaundice and Alcoholic hepatitis.
Patients with Infective Hepatitis - Patients started the treatment with mean serum bilirubin levels of 8.38 ± 1.02 mg/100 ml. After 5 days of treatment, the serum bilirubin level had fallen to 5.46 ± 0.88 mg/100 ml. After 12 days of treatment, the serum bilirubin levels had fallen to 2.57 ± 0.57 mg/100 ml.
Patients with Anti-tubercular drugs induced jaundice - Patients started the treatment with serum bilirubin levels of 5.6 mg/l00 ml. After 12 days of treatment, the serum bilirubin level had fallen to 2.3 mg/100 ml.
Patients with Alcoholic hepatitis - Patients started the treatment with serum bilirubin levels of 4.75 mg/100 ml. After 12 days of treatment, the serum bilirubin level had fallen to 1.4 mg/100 ml.
Kamalahar showed significantly good results in the treatment of Infective Hepatitis, Anti-tubercular drugs induced jaundice and Alcoholic hepatitis.
Patients with Infective Hepatitis - Patients started the treatment with mean serum bilirubin levels of 8.38 ± 1.02 mg/100 ml. After 5 days of treatment, the serum bilirubin level had fallen to 5.46 ± 0.88 mg/100 ml. After 12 days of treatment, the serum bilirubin levels had fallen to 2.57 ± 0.57 mg/100 ml.
Patients with Anti-tubercular drugs induced jaundice - Patients started the treatment with serum bilirubin levels of 5.6 mg/l00 ml. After 12 days of treatment, the serum bilirubin level had fallen to 2.3 mg/100 ml.
Patients with Alcoholic hepatitis - Patients started the treatment with serum bilirubin levels of 4.75 mg/100 ml. After 12 days of treatment, the serum bilirubin level had fallen to 1.4 mg/100 ml.